Cargando…

The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer

The CRISPR-Cas system was identified in bacteria as an immune defense mechanism against threats from the external environment. A common form of this system, called CRISPR-Cas9, is now widely used in gene editing, especially in mammalian cells. Through CRISPR-Cas9, gene knock-ins or knock-outs have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiayu, Zhou, Wenlong, Wang, Xiaoxuan, Wang, Lihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086466/
https://www.ncbi.nlm.nih.gov/pubmed/35548117
http://dx.doi.org/10.1039/c8ra04509g
_version_ 1784704007333216256
author Zhang, Jiayu
Zhou, Wenlong
Wang, Xiaoxuan
Wang, Lihui
author_facet Zhang, Jiayu
Zhou, Wenlong
Wang, Xiaoxuan
Wang, Lihui
author_sort Zhang, Jiayu
collection PubMed
description The CRISPR-Cas system was identified in bacteria as an immune defense mechanism against threats from the external environment. A common form of this system, called CRISPR-Cas9, is now widely used in gene editing, especially in mammalian cells. Through CRISPR-Cas9, gene knock-ins or knock-outs have become more feasible, thus deepening our understanding of the mechanisms of human diseases, including cancers, and suggesting possible treatment strategies. In this review, we discuss how CRISPR-Cas9 can be used as a tool to discover more about drug-resistance in cancers, including both the underlying mechanisms and ways to overcome them.
format Online
Article
Text
id pubmed-9086466
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90864662022-05-10 The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer Zhang, Jiayu Zhou, Wenlong Wang, Xiaoxuan Wang, Lihui RSC Adv Chemistry The CRISPR-Cas system was identified in bacteria as an immune defense mechanism against threats from the external environment. A common form of this system, called CRISPR-Cas9, is now widely used in gene editing, especially in mammalian cells. Through CRISPR-Cas9, gene knock-ins or knock-outs have become more feasible, thus deepening our understanding of the mechanisms of human diseases, including cancers, and suggesting possible treatment strategies. In this review, we discuss how CRISPR-Cas9 can be used as a tool to discover more about drug-resistance in cancers, including both the underlying mechanisms and ways to overcome them. The Royal Society of Chemistry 2018-09-28 /pmc/articles/PMC9086466/ /pubmed/35548117 http://dx.doi.org/10.1039/c8ra04509g Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Zhang, Jiayu
Zhou, Wenlong
Wang, Xiaoxuan
Wang, Lihui
The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer
title The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer
title_full The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer
title_fullStr The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer
title_full_unstemmed The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer
title_short The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer
title_sort crispr-cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086466/
https://www.ncbi.nlm.nih.gov/pubmed/35548117
http://dx.doi.org/10.1039/c8ra04509g
work_keys_str_mv AT zhangjiayu thecrisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer
AT zhouwenlong thecrisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer
AT wangxiaoxuan thecrisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer
AT wanglihui thecrisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer
AT zhangjiayu crisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer
AT zhouwenlong crisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer
AT wangxiaoxuan crisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer
AT wanglihui crisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer